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ABSTRACT 
Since its discovery in the beginning of the XXth century, squalene has been recognized as an 
important link in metabolic pathways. More recently, it has been further recognized as an 
intermediate step in the biosynthesis of cholesterol. Its well known antioxidant capability, 
together with its ability to protect skin, improve the immune system, and modulate the lipid 
profile, confer a high potential to this natural substance, which is spread all across the body 
structure,  though  mainly  in  the  epithelial  tissues,  and  in  particular  the  skin  sebum.  This 
review will focus mainly on its major properties, which are related to anticancer properties, 
the  maintenance  of  the  oxidation/antioxidation  balance,  and  its  antiaging  capabilities. 
Although the substance was originally obtained from shark liver oil, it is currently possible to 
obtain useful amounts from vegetable sources like extra virgin olive oil, therefore avoiding 
the dependence on capturing the aforementioned animal species.  Recognized as one of the 
key  components  of  the  Mediterranean  dietary  style,  squalene  is  necessary  to  adequately 
manage oxygen and its derivatives in every cell of the body.   
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Sources and structure 
Inhabitants of the Japanese Peninsula of Izu used to drink an oil that was locally named 
“Samedawa,”  which  means  “cure  all”.  In  1916,  Dr.  Mitsumaru  Tsujimoto,  a  Japanese 
industrial engineer, described ten years after his initial discovery that Samedawa contained 
extremely large quantities of an unsaturated hydrocarbon [1]. He named the hydrocarbon 
squalene, due to its presence in the liver oil of sharks, from the Latin root “squalus” (shark). Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 463 of 476 
 
Ten years later, its structure was established as a dihydrotriterpene, and the authors posited 
that it might be an intermediary in the biosynthesis of steroids [2]. 
 In 1934, Robinson proposed a direct cyclization of squalene to the steroid molecule 
[3]. In 1936, Nobel laureate researcher Paul Karrer described the biochemical structure of 
squalene for the first time. He was already recognized for his discoveries on the chemical 
structures of Vitamins A and E [4].  
The biochemical structure of squalene is C30H50 (C30:6n-Ω2), a 30-carbon compound 
(polyprenyl, holding 6 prenyl groups, better known as isoprenoid or isoprene) (Figure 1).  
 
Figure 1. Chemical structure of squalene 
 
Due  to  a  double  bond  structure  of  six  CH3  groups,  the  isoprenoid  has  a  strong  natural 
antioxidative  effect.  Squalene  has  a  similar  structure  to  other  isoprenoids  as  β-carotene, 
lycopene, vitamin A, vitamin E, and coenzyme Q10 (ubiquinone) [5].   
Until today, shark liver oil is considered the richest source of squalene, with squalene 
accounting for at least 40% of its weight. It is also widely distributed in nature, in lesser 
proportions in amaranth oil (6-9%) [6], in wheat germ oil, and in olive oil (usually from 0.4% 
up to 1% in extra virgin olive oil) [7].  Evidence suggests that 60 to 80% of dietary squalene 
is absorbed from dietary intake [8,9]. Squalene was first found in the human body in the 
1950’s,  when  the  metabolism  of  cholesterol  was  first  identified  [10].  Not  long  ago, 
knowledge spread that squalene is  one of our body’s own essential substances,  which is 
present in small quantities in the skin and blood: the body synthesizes an average amount of 
1.5 g/day [11]. Although the skin of primates has virtually no squalene, 12% of overall bodily 
squalene content in humans is in the sebum secreted by the skin. Furthermore, the daily 
secretion of squalene from the total skin surface ranges from 125 up to 475 mg/day [12]. 
 
Actions on the lipid profile: the best known history 
Squalene is an intermediate step in the biosynthesis of cholesterol and all steroid hormones. It 
is  an  inhibitor  of  the  3-hydroxy-3-methylglutaryl  Coenzyme  A  (HMG-CoA)  reductase 
activity and increases the activity of acyl CoA cholesterol acyltransferase [12]. In fact, the 
endogenous  synthesis  of  squalene  begins  with  the  production  of  HMG-CoA.  The  initial 
reduction  of  HMG-CoA  results  in  the  formation  of  mevalonate  [13].  Cholesterol  is 
synthesized in a complex series of biochemical steps, known as the mevalonate pathway. 
After some biochemical reactions, featured by the addition of prenyl groups, the molecules of 
the  intermediate  group  farnesyldiphosphate  are  gathered  and  reduced,  resulting  in  the 
formation of squalene. After its biosynthesis, squalene can be transported to other regions of 
the  body  to  be  incorporated  in  tissues,  or  to  be  metabolized,  resulting  in  the  eventual 
synthesis of cholesterol and its steroid metabolites [14]. 
The presence of squalene in the cells affects the HMG-CoA reductase synthesis rate, 
which  in  turn  affects  the  whole  synthesis  of  isoprenoids  and  cholesterol.  This  offers 
possibilities for the prevention and treatment of high levels of “bad cholesterol,” a risk factor 
for  cardiovascular  disease.  However,  “bad  cholesterol”  is  not  the  only  factor  in Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 464 of 476 
 
cardiovascular disease risk: when “bad cholesterol” is attacked by free radicals, it becomes an 
even more harmful substance, oxidized cholesterol (oxLDL), which is known as the worst 
cholesterol [15].  
 
Squalene’s workplace: the cell membranes 
Currently,  squalene  protects  the  cellular  and  the  cytoplasmatic  organoids’  biomembranes 
from oxidative stress, as well contributing to maintaining order in the cholesterol metabolism 
and  keeping  harmful LDL-cholesterol at minimal levels [16]. Biomembranes are themselves 
highly vulnerable to the harm caused by free radicals, especially in the hydrophobic band 
between the two lipidic layers. Squalene is outstanding because of its  great capability to 
receive or donate electrons without suffering a molecular alteration. Such stable and effective 
antioxidant configuration is given by its six isoprenoid units. Squalene can have two different 
forms: cyclic and noncyclic. The noncyclic form is entirely hydrophobic and is not engaged 
to  the  biological  membrane.  It  is  attracted  by  the  band  between  both  lipidic  layers,  the 
intermembrane. It accumulates there and performs its antioxidant task, capturing free radicals 
[5].  
Certain experimental models propose that hydrocarbons such as squalene, specifically 
located in the middle of the lipid bilayer, inhibit proton leaks, which are events that consume 
cellular  energy  in  an  unproductive  way  [17].  In  particular,  polyunsaturated  fatty  acids 
(including those in foods containing lipids) are prone to suffering from oxidation, and this 
plays an important role concerning the integrity of biological membrane. The capability of 
squalene  to  protect  the  linoleic,  linolenic,  docosahexaenoic,  and  eicosapentaenoic  acids 
against temperature-dependent self-oxidation is outstanding [18]. 
A  relevant  point  related  to  cholesterol  synthesis  and  antioxidant  actions  is  the 
cyclization of squalene to lanosterol, already described in the 50’s [19], and dependent on the 
oxygen  catchment  by  squalene  [20]  –in  fact,  it  is  oxydosqualene.  Under  certain  given 
conditions, the noncyclic squalene loses its stability and curls itself, becoming cyclic and 
losing an important part of its antioxidant potential. It instead becomes the steroid nucleus. 
The molecules of cyclic squalene are known as hopanoids. It is not exactly known how this 
transformation takes place, but the noncyclical molecule enters into a cavity of a protein 
complex,  it  is  divided  into  its  six  isoprenoids  and  then  further  reassembled  into  a  new 
configuration. This is mandatory for being able to become the nucleus of cholesterol and 
other sterols [5]. 
In order to stabilize, squalene also attaches hydrogen ions from water and acids in the 
body, and in the process, releases oxygen to the body by the following reaction:  C30H50 
(squalene) + 6 H2O (water) -> C30H62 (squalane)+ 3 O2 (oxygen) [20]. 
Squalene facilitates oxygen to reach the cellular level, causing further improvement in 
organ function through aerobic metabolism, which prevents acidotic cell syndrome, where 
cells become acidic, deteriorate, and die due to hypoxia [5]. 
 
Actions as anticancer agent 
Extra virgin olive oil contains small amounts of bioactive substances, which usually do not 
exceed 2% of its weight. Nevertheless, in spite of their small amount, these substances have a 
large  series  of  properties  which  are  beneficial.  Among  them,  the  anticarcinogenic  and 
antioxidant capabilities are outstanding. These minor components include polyphenols within 
a range of 100-500 mg/kg according to different authors [21]. The major part is formed by Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 465 of 476 
 
alcohols (tyrosol, hydroxytyrosol), but there are also other compounds such as flavonoids, 
lignans, and triterpenes. In regards to triterpenes, squalene is remarkable. A series of reviews 
have accepted that minor components of olive oil are potentially anticarcinogenic [22]. 
We recently performed a review of the relevant literature in Pubmed (5/July/2013) with 
the  term  “squalene”  producing  3281  results,  which  have  reached  from  the  year  1926  up 
through 2013, most of which proceed from basic research. When the search added the term 
“cancer,”  results  were  restricted  to  203,  with  the  oldest  one  being  from  1956,  mainly 
involving studies linking squalene to the protection against skin cancer. Undoubtedly, the 
links between squalene and cancer are more recent than most of the previous studies, which 
relate this substance with cholesterol, steroid molecules, and cardiovascular and metabolic 
areas. 
We have mentioned that squalene is chemically an isoprenoid, sharing that structure 
with  carotenoids  like  lycopene,  with  vitamins  A  and  E,  and  also  with  other  endogenous 
antioxidants as glutathione, superoxide dismutase, and ubiquinone (coenzyme Q10). All of 
these  are  powerful  antioxidants.  The  previous  paragraphs  have  remarked  the  extreme 
vulnerability of biomembranes to oxidative harm due to oxygen free radicals, especially in 
the hydrophobic band between the lipid bilayer. Squalene, usually located in this cellular 
zone,  has  an  outstanding  antioxidant  capability  recognized  because  of  its  highly  stable 
structure. This  capability is of major importance concerning the protective action against 
cancer (mainly thinking about reducing DNA damage), which has been remarked by the 
scientific literature. 
The literature also recognizes in squalene an optimizing factor for the immune system. 
This  has  been observed in  macrophages  as  well  as  in  lymphocytes.  Five decades  ago,  a 
published paper showed that squalene stimulates macrophages [23]. The evidence suggests 
that the biomembrane of immune cells is protected by squalene during phagocytosis, which 
makes them resistant to oxidative stress elements that such cells receive as an attack. The 
synthesis  and  consumption  of  squalene  might  be  increased  in  those  moments,  like  other 
antioxidants such as glutathione do. It has been found that two squalene precursors (geranyl 
and farnesyl) influence the synthesis and secretion of cytokines, which regulate the immune 
response. Interestingly, squalene precursors also regulate cellular growth and proliferation. 
Ras is the most common family of oncogenes, found in 30% of cancers. Cancer cells 
activate the ras gene, which in turn synthesizes ras proteins and performs ras functions. The 
oncogenic  ras  protein  is  in  a  continuous  activation  state,  leading  to  an  uncontrolled  cell 
division in the absence of growth signals [24]. The activation of these proteins depends on the 
isoprenoid metabolism in the neoplastic cells. Through isoprenylation, farnesylpyrophosphate 
fixes the ras protein to the cell membrane, and it also fixes some other important proteins to 
the cell membrane or to the nuclear cover. Without this vital step, the ras oncogene finds 
severe limitations for its activity [25]. Regarding the cell cycle, a G1 phase moving towards S 
phase  requires  two  products  of  the  mevalonate  pathway  for  the  protein  isoprenylation: 
geranyl- and farnesylpyrophosphate [26,27].  Research results support the idea that inhibition 
of lipid metabolic pathways may be valuable as a possible molecular target for collaborating 
in the treatment of some cancers, e.g. lung [28], breast [29], esophagus [30], and sarcomas 
[31]. 
Farnesylpyrophosphate is of interest, because of its place in the isoprenoid synthesis 
pathway  and  its  dependence  on  the  HMG-CoA  reductase.  The  presence  of  exogenous 
squalene establishes a negative feedback by inhibition of HMG-CoA reductase, then reducing Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 466 of 476 
 
the  farnesylpyrophosphate  synthesis,  disrupting  the  synthesis  of  mevalonate  pathway  and 
inhibiting the protein isoprenylation. The latter is even more important in tumor cells than in 
normal ones, especially when the ras oncogene is hyperactivated [32]. As a consequence, its 
disruption is deleterious for the cancer cell. If squalene achieves a stop in the G1 phase of this 
cell, it prevents cellular growth and proliferation [5]. A daily intake of squalene can inhibit 
the isoprenoid production in neoplastic cells and present an obstacle for their growth and 
development. Some authors have found this to be a possible explanation for the anticancer 
properties of olive oil [25].   
The presence of ROS (reactive oxygen species) is involved in several biological facts 
which  typically  take  place  in  the  initiation  and  progression  of  cancer,  according  to  the 
hypothesis of persistent oxidative stress in cancer [33]: a) they can originate a persistent 
activation of transcription factors as Nuclear Factor kappa B (NFκB); b) they can induce the 
expression of proto-oncogenes such as c-fos, c-jun and c-myc; c) oxidative stress can result in 
tumor cells developing resistance to chemotherapy; d) reactive oxygen can damage certain 
proteins and enzymes, including protease inhibitors, probably facilitating tumor invasion and 
metastases. 
Experimental research has shown a protective activity of olive oil against chemically 
induced carcinogenesis in  the breast  gland [34], colon  [35], skin [36], and liver [37]. In 
particular,  topical  application  of  squalene  showed  anticarcinogenic  activity  [38,39]. 
Concerning the involved mechanisms, researchers have found that minor compounds have an 
impact on cell death and proliferation. Besides this, most nutrigenomic studies of olive oil 
were conducted in cancer research [40-44]. 
A dietary enrichment with the unsaponifiable fraction of olive oil reduces the damage 
of  acute  colitis,  alleviating  the  oxidative  events  and  returning  the  expression  of 
proinflammatory proteins to basal levels, probably through inhibition of signaling pathways 
of  p38,  Mitogen-activated  protein  kinase  (MAPK),  Cyclo  Oxygenase-2  (COX-2),  Nitric 
oxide synthase (iNOS), NFkB, and by enhancement of the Peroxisome Proliferator-Activated 
Receptor-gamma (PPAR-γ) pathway [45,46]. Since this disease is a potential risk factor for 
colorectal cancer, the increase of unsaponifiable fraction could contribute to the prevention of 
such a tumor. 
Two leading scientists in the field of nutrition and cancer, Theresa Smith and Harold 
Newmark, have suggested that the protective effect of extra virgin olive oil could be due to 
its  squalene  content  [8,  25],  a  concept  based  on  a  considerable  amount  of  experimental 
studies in animals. Most of these studies investigated the effect of squalene when topically 
applied  or  in  a  systemic  way  on  chemically  induced  cancers  of  skin,  colon,  or  lungs  in 
rodents.  Rao  et  al.  supported  Newmark’s  hypothesis,  also  suggesting  that  squalene,  as  a 
component of olive oil, could be partially responsible for the chemopreventive effect of the 
oil [47]. Considered together, these results clearly show that dietary squalene has different 
anticarcinogenic effects [38, 47-50]. 
In 1999, D.A. Hertzler et al. cited  a review which [51] proposed that squalene had the 
potential to be part of a chemotherapy regimen for human pancreatic cancer. 
Squalene  is  capable  of  inhibiting  aberrant  hyperproliferation,  a  cellular  marker 
associated with preneoplastic transformation [52]. Other authors have investigated the effect 
of  squalene  on  antitumoral  activity  and  immune  response  of  the  host  in  female  rodents 
bearing sarcoma 180. The intraperitoneal administration of squalene was seen to enhance the Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 467 of 476 
 
function of the reticuloendothelial system, in particular antibodies IgM, and a longer survival 
was observed in the animals [53]. 
The administration of squalene at 2% in the diet of rodents 14 days before and 30 days 
after a lethal  total  body irradiation with  γ-rays,  was  followed  by  a  cellular  and  systemic 
radioprotection. White blood cell count was consistently higher among the animals treated 
with squalene. This treatment was associated with a significant extension of survival time 
compared to the control group [54]. Beside this, the genotoxicity of doxorubicin has been 
reduced through administration of complementary squalene in rats [55]. The protection of 
bone marrow against the action of some antineoplastic drugs has been also documented [56]. 
Furthermore, this author’s results suggest that squalene has a cytoprotective effect in vitro on 
pluripotential hematopoietic cells derived from bone marrow but does not protect cell lines of 
neuroblastoma from the toxicity induced by cisplatin [57]. According to this study, squalene 
would have a selective cytoprotective activity in normal cells against toxicity produced by 
chemotherapy, without protecting tumor cells.  
Although  the  evidence  supporting  the  use  of  squalene  in  combination  with 
chemotherapy agents against cancer in humans is somehow reduced, such evidence suggests 
that squalene can potentiate the cytotoxic activity of some of those agents. The effect of 
squalene combined with ACNU (a nitrosourea) in a murine tumoral model, at doses of 4.2 
g/kg has shown capabilities of potentiating the effect of ACNU against lymphoid leukemia. 
The authors reported a longer survival of some animals, without toxicity [48]. Survival in 
cultured cell lines indicates that squalene also increased cytotoxicity and antitumoral activity 
of  adriamicin,  cyclophospamide,  5-fluoruracil,  bleomicin,  and  cisplatin.  The  strongest 
potentiation effect was seen in bleomicin [58]. Basic research about squalene in breast cancer 
cell lines was recently carried out, emphasizing the increase in the cytotoxicity of adriamicin 
as well as an increase of antioxidant activity for normal cells [24]. Myelo- and nephrotoxicity 
due to agents like cisplatin and cyclophosphamide take place because of the generation of 
free radicals or because of the enhancement of oxidative metabolism. It is there that squalene 
is  able  to  minimize  certain  tissue  damages,  in  addition  to  potentiating  cytotoxicity  in 
cancerous cells [59]. We can recognize, therefore, that there seem to be significant powerful 
antioxidant and cytoprotective effects in squalene.  
The convenience of combining the nutritional-pharmacologic effects in which squalene 
participates had already been suggested some years ago [60], regarding a combination of 
olive  oil  together  with  sulindac  (as  a  COX-2  inhibitor),  which  represents  an  advantage 
considering the practical feasibility of this combination.  
In a recent publication on nutrition and breast cancer [61], we have emphasized the 
potentially high usefulness of squalene as supplement with a double purpose: On one hand, 
collaborating with a nutritional style for the prevention of the disease; on the other hand, 
collaborating with different oncospecific therapies that patients must usually receive. 
 From  surgery  through  radiotherapy  and  also  chemotherapy,  there  is  a  space  for 
coadjuvance with squalene in the treatment. Tumor cells live better in environments reached 
by small amount of oxygen (anaerobic ones), and oxygenation is harmful for them: this is 
obviously well known by specialists. A sustained acidosis is a potential upstream and indirect 
trigger in a multifactorial cascade of molecular events associated with carcinogenesis. The 
extracellular space of most tumors is mildly acidic, due to an exuberant production of lactic 
acid. There is growing evidence that extracellular acidity per se boosts the invasiveness and 
metastatic capacity of cancer cells [62]; moreover, this acidity renders cancer cells relatively Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 468 of 476 
 
resistant to the high proportion of chemotherapeutic drugs that are mildly basic, and may 
impede  immune  rejection  of  tumors  [63].  If  the  whole  body  is  better  oxygenated,  the 
cytotoxicity of radio- and chemotherapy on malignant cells will be enhanced, and the oxygen 
will contribute to the protection of healthy cells (which are the majority). The quoted ability 
of  squalene  to  neutralize  a  proton  excess  derived  from  metabolism  could  be  somehow 
associated to the alkalizing action of fruits and vegetables, which has scientific support [64].  
Squalene  appears  to  have  twice  the  capability  of  wiping  the  harmful  oxygen  and 
distributing the useful oxygen. Hence, there is an opportunity to profit from such potentiality 
without the risks of a pharmaceutical drug.  
As an adjuvant therapy for cancer in humans, the information about the optimal doses 
is not available either. Anyway, if liver steatosis emerges as a consequence of some state-of-
the-art cancer therapy, squalene appears as a helpful tool with the ability to normalize the 
situation, since it contributes to hepatic detoxification. Some experimental researchers have 
reported that animals fed with squalene show an enhanced capacity to excrete toxins such as 
hexachlorobenzene or strychnine [65-67]. Squalene can attract xenobiotic products which are 
highly lipophilic, contributing then to their body elimination [68]. As an extrapolation from 
available animal data, a dose between 2-5 g/day seems to be the therapeutic window. The 
experience in the therapy of chronic lead toxicity in Uruguayan children has been very useful 
[69], profiting from the high detoxifying capability of squalene. The researchers employed 
doses  up  to  6.5  g/day  without  any  signs  of  toxicity  or  intolerance.  The  aforementioned 
experience  without  adverse  side  effects  could  be  useful  as  a  reference  for  its  clinical 
administration,  also  taking  into  account  the  different  ratio  dose  (g)/body  weight  (kg)  in 
children.   
In  conclusion,  we  could  say  that  the  epidemiological,  experimental  and  clinical 
evidence about the anticancer properties of squalene are promising. This substance could 
have a place as an adjuvant together with specific oncologic therapies. Furthermore, in the 
light of the existing evidence, we do not find any strong arguments against the intake of 
squalene among cancer patients within a range of 2-6 g/day.  
 
Actions as an antiaging agent 
According  to  the  World  Health  Organization,  aging,  or  senescence,  is  “the  series  of 
morphologic and physiologic changes which appear as a consequence of the action of time on 
living beings, which supposes a reduction of adaptive capabilities in each one of the organs 
and systems, as well as in the capability of response to harmful agents with incidence in the 
individual” [70]. 
Aging  is  a  complex  process  which  is  expressed  in  an  organism  at  several  levels: 
genetic, molecular, cellular, in organs, and in systems. Albeit, the fundamental mechanisms 
are still not well known, there is increasing evidence pointing to the “reactive species” of 
oxygen and nitrogen, as one of the primary determinants of aging. The theory of oxidative 
stress states that a progressive and irreversible accumulation of oxidative damage caused by 
reactive  species  impacts  critical  aspects  of  the  aging  process,  contributing  to  damaged 
physiological functions,  a higher incidence of diseases, and a reduction in life extension [71].   
Research has generated very strong data which supports the theory of oxidative stress. 
Nevertheless, a direct cause-effect relationship between the accumulation of damage due to 
oxidation and aging has not been clearly established [72]. The oxidative damage of cellular 
and  tissular  components  is  located  among  the  primary  or  secondary  factors  in  the  aging Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 469 of 476 
 
process  as  well  as  in  different  human  diseases  (e.g.  cardiovascular,  cancer,  diabetes, 
neuromuscular disfunctions, and degenerative processes) [73]. 
Oxidative  stress  refers  to  a  serious  imbalance  between  the  production  of  reactive 
species and antioxidant defenses. The degree of stress is determined by the quoted balance or 
imbalance level. Regardless of how or where reactive species are generated, an increase of 
intracellular concentrations of oxidants has two important and potential effects: a) several 
cellular  components  are  damaged  [74,75];  and  b)  the  activation  of  specific  signaling 
pathways is triggered [74-76]. 
Both  effects  can  influence  numerous  cellular  processes  related  to  aging  and  the 
development of diseases related to age. Oxidative stress status is under a strong regulatory 
control for most people, based on a wide range of lifestyle variables, which include diet and 
physical activity. 
It has been shown that a high level of oxidative stress in humans could be reduced to a 
normal level through antioxidant supplements [73]. This fact has clinical implications but 
also  gives  another  important  message:  a  daily  dietary  which  is  simply  rich  in  natural 
antioxidants could prevent and defend our organism against the incidence of diseases which 
are age-associated. 
A Mediterranean-type diet was already observed in the 90’s as good for human health, 
reducing the incidence of coronary diseases [77] and certain types of cancer [78]. Because of 
its abundant foods which were rich in vitamins, antioxidants, and monounsaturated fatty acids 
–all of them being potentially active in the protection against diseases associated to age--the 
Mediterranean  diet  was  recognized  as  a  “functional  diet”  which  protects  human  health 
[79,80]. Experimental studies carried out in the past decade in human volunteers [81-84] 
showed that some of the minor components of olive oil (polyphenols, squalene) contributed 
significantly towards its benefits on health. After a meal rich in fats, an oxidative stress takes 
places and triggers inflammation, endothelial disfunction, hypercoagulability, and a cascade 
of other atherogenic changes [85]. However, the intake of fatty foods with adequate sources 
of  antioxidants,  like  a Mediterranean-type  meal,  can  minimize  the  postprandial  oxidative 
stress [86]. 
In this review we have already mentioned that squalene works as a powerful scavenger 
of oxygen free radicals, hence inhibiting the lipoperoxidation induced e.g. by UV radiations 
[87]. Besides this, its capability for the inhibition of HMG-CoA reductase stops cholesterol 
biosynthesis while it facilitates its excretion through bile [88]. In addition, squalene generates 
a modulation on the action of immune system on the arteries, something fundamental in order 
to stop atherogenesis [89,90]. This has also been recognized for other minor components of 
olive  oil  [91,92].  The  arterial  protection  determined  by  these  facts,  together  with  the 
recognized  antioxidant  capability  of  dietary  squalene,  somehow  represents  an  antiaging 
action, since arterial age is closely associated to its level of atherosclerosis. Aging makes the 
maintenance of the oxidation/antioxidation balance even more difficult, because the body’s 
own antioxidant synthesis –in the same way the one of other important nutrients- declines 
with the advance of age.    
It is interesting to remark that the interventions with components rich in antioxidants at 
dietary doses in healthy volunteers exert only marginal effects. In addition, detecting those 
effects could be difficult due to the current status of oxidative biomarkers [93]. In fact, the 
protective effect of minor components of olive oil on the oxidative damage in humans was 
better displayed in participants with a compromised oxidative status (men having a low-Functional Foods in Health and Disease 2013; 3(12):462-476                                                   Page 470 of 476 
 
antioxidant diet, postmenopausal women) or in patients with a high status of oxidative stress 
(hyperlipidemic, coronary disease, hypercholesterolemic, etc). 
The same facts were observed by us in epidemiological studies related to nutrition and 
cancer [94,95]. For example, the increase of intake of Ω-3 fatty acids through diet as well as 
through supplementation (and the same in the case of vegetables and fruits intake) suggest 
that there would not be a protective effect (or perhaps it might be strongly reduced) among 
those who have higher intake of them. On the contrary, when their negative risk association 
(protective effect) was stronger, the higher was the deficit prior to diagnosis. Observations 
suggest  that  when  the  oxidant/antioxidant  status  is  adequate,  it  cannot  be  significantly 
improved by the addition of antioxidant foods. Conversely, the potentially beneficial effect of 
the latter is higher, as higher is the previous imbalance (oxidative stress). 
Olive oil, as the complex food it is, can have a series of direct and indirect effects on 
genetic expression. The direct effect is the interaction with a series of transcription factors 
which are responsible for the positive-negative regulation of genic expression. The indirect 
effects refer to the interaction related to the metabolism on the cascades of cellular signaling 
which  modify  the  genic  transcription  [96-98].  Several  genes  have  been  identified  in 
experimental animal models as responders to the intake of olive oil [99]. 
 
Concluding remarks 
Squalene, an unsaturated compound, appears to contribute to the formation of useful oxygen 
when combined with water, and also to the efficient transportation of that useful oxygen to 
the whole body, helping in that way to maximize the catchment of such element. Having that 
capability, the likelihood of generating underoxygenated microenvironments which produce 
metabolic acidosis using anaerobic metabolism is reduced. The main problem derived from 
those  anaerobic  environments  is  that  they  facilitate  the  development  of  degenerative 
pathologies and cancer, among other alterations. These concepts are equivalent to saying that 
an adequate intake of squalene is preventive of cell aging, since it adequately maintains the 
nutritional levels of the requested oxygen. 
The present review intended to briefly outline and discuss some important roles that 
squalene  plays  in  the  human  body.  It  can  be  distinguished  by  the  common  property  of 
antioxidant and oxygen administrator and it could be considered as a biological response 
modifier, regarding oxygen, the immune system and steroid synthesis. The impact on oxygen 
behavior  also  determines  a  control  on  inflammation  processes,  tightly  linked  to  the 
development  of  several  prevalent  chronic  diseases  as  cancer.  If  all  these  were  not  even 
considered enough to accept squalene as an outstanding substance, its detoxifying capability 
against xenobiotic products is another advantage as regards its performance. In view of the 
high  concentration  differences  of  squalene  between  shark  liver  oil  (≥60%)  and  olive  oil 
(≤1%), and also taking into account the ecological impact of capturing marine species, it 
would be desirable to have higher squalene concentrations in vegetable sources like olive oil 
(in which it is also enhanced by the action of other minor components), as an eco-friendly 
alternative. 
According  to  the  scientific  literature  and  to  our  knowledge,  no  specific  medical 
syndrome due to squalene deficiency has been described. In the opinion of the authors, this 
fact  does  not  preclude  us  to  think  of  squalene  as  essential  for  life  and,  furthermore,  to 
consider it a must of healthy nutrition in modern times. 
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